LAMOUREUX FRANÇOIS,GLEAVE MARTIN E.,ZOUBEIDI AMINA
申请号:
NZ61647412
公开号:
NZ616474A
申请日:
2012.03.12
申请国别(地区):
NZ
年份:
2015
代理人:
摘要:
The disclosure relates to the use of an oligonucleotide which reduces clusterin expression and a Heat Shock Protein 90 (Hsp90) inhibitor of the formula shown in the abstract figure for the treatment of prostate cancer. The disclosure also relates to pharmaceutical compositions comprising an amount of an oligonucleotide which reduces clusterin expression, and an Hsp90 inhibitor.